Ventaris Surgical
Develops a ureteroscopic system for complete kidney stone clearance
$30MSeries A
Role not disclosedLC
Longitude Capital
Activity from announced rounds
All recorded activity
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $230M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in all activityAirNexis Therapeutics
AirNexis Therapeutics develops medicines for pulmonary diseases, led by the investigational COPD candidate AN01.
$200MSeries A
Role not disclosed